ArticleAntimicrobial agents and chemotherapy2017
Role of
Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 25 citations in OpenAlex.
- Article
- Beyond the matrix: rethinking antibiotic tolerance in CF biofilms using 3D models.NPJ biofilms and microbiomes · 2025Article
- Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility.Nature reviews. Microbiology · 2025Review
- Article
- The role of exopolysaccharides Psl and Pel in resistance ofMicrobiology spectrum · 2024Article
- Role of Pel and Psl polysaccharides in the response ofMicrobiology (Reading, England) · 2023Article
- The role of individual exopolysaccharides in antibiotic tolerance ofFrontiers in microbiology · 2023Article
- The novel type II toxin-antitoxin PacTA modulates Pseudomonas aeruginosa iron homeostasis by obstructing the DNA-binding activity of Fur.Nucleic acids research · 2022Article
- Characteristics of Antibiotic Resistance and Tolerance of Environmentally EndemicAntibiotics (Basel, Switzerland) · 2022Article
- Pseudomonas aeruginosa polysaccharide Psl supports airway microbial community development.The ISME journal · 2022Article
- Search for a Shared Genetic or Biochemical Basis for Biofilm Tolerance to Antibiotics across Bacterial Species.Antimicrobial agents and chemotherapy · 2022Article
- Autoinducer Analogs Can Provide Bactericidal Activity to Macrolides inAntibiotics (Basel, Switzerland) · 2021Article
- Clinical Significance of Carbapenem-TolerantAntibiotics (Basel, Switzerland) · 2020Article
- Mechanisms for Rapid Evolution of Carbapenem Resistance in a Clinical Isolate ofFrontiers in microbiology · 2020Article
- Regulation of Exopolysaccharide Production by ProE, a Cyclic-Di-GMP Phosphodiesterase inFrontiers in microbiology · 2020Article
- Conceptual Model of Biofilm Antibiotic Tolerance That Integrates Phenomena of Diffusion, Metabolism, Gene Expression, and Physiology.Journal of bacteriology · 2019Article
- Effects of PslG on the Surface Movement of Pseudomonas aeruginosa.Applied and environmental microbiology · 2018Article
- Coping with Environmental Eukaryotes; Identification ofMicroorganisms · 2018Article
- Cyclic-di-GMP andFrontiers in microbiology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 2 countries.
Funding
Abstract
Bacteria attached to a surface are generally more tolerant to antibiotics than their planktonic counterparts, even without the formation of a biofilm. The mechanism of antibiotic tolerance in biofilm communities is multifactorial, and the genetic background underlying this antibiotic tolerance has not yet been fully elucidated. Using transposon mutagenesis, we isolated a mutant with reduced tolerance to biapenem (relative to that of the wild type) from adherent cells. Sequencing analysis revealed a mutation in the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.